Lastly, future investigations should consider stratification by breast cancer subtype (e.g., estrogen receptor-positive, HER2-positive, triple-negative) to determine whether microbiota-related dietary interventions may offer subtype-specific preventive benefits. This evidence concerns the gene ESR1 and breast carcinoma.